Target intelligence / Profile preview

General cellular and extracellular matrix components

Molecular classification
Other
01

Overview

General cellular and extracellular matrix (ECM) components encompass the complex network of proteins, such as collagens and elastins, and polysaccharides that provide structural and biochemical support to cells (Frantz et al., 2010, J Cell Sci). This category is not a single therapeutic target but a broad biological compartment essential for tissue integrity, cell signaling, and homeostasis (Lu et al., 2012, J Cell Biol). In diseases like cancer, the ECM is often remodeled to promote tumor invasion and chemoresistance, while in fibrotic diseases, it becomes excessively stiff and accumulated (Winkler et al., 2020, Nat Commun). Pharmacological interventions typically target specific ECM constituents or their receptors, such as integrins or matrix metalloproteinases, rather than the matrix as a whole (Naba et al., 2016, BMC Cancer). Consequently, this term is considered a descriptive category or a biological environment rather than a specific, druggable molecular entity.

Other names
Extracellular matrixECMIntercellular matrixMatrisomeConnective tissue matrix
02

Mechanism of action

Enzymatic degradation of matrix components, inhibition of cell-adhesion receptors (integrins), or modulation of matrix cross-linking and synthesis.

03

Biological functions

Structural supportCell adhesionCell signalingTissue organizationGrowth factor sequestrationMechanical force transduction
04

Disease associations

CancerFibrosisCardiovascular diseaseOsteoarthritisGenetic connective tissue disordersScleroderma
05

Safety considerations

Systemic toxicity due to ubiquitous distributionImpaired wound healingPotential for musculoskeletal side effectsTissue fragilityOff-target effects on healthy tissue architecture
06

Interacting drugs

Hyaluronidase

5 more in the full profile.

07

Biomarkers

Matrix metalloproteinases (MMPs)Collagen degradation products (e.g., CTX-I)FibronectinPro-collagen type III N-terminal peptide (PIIINP)

Beyond the preview

Go deeper on General cellular and extracellular matrix components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General cellular and extracellular matrix components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call